Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-20

FDA Approved: LETROZOLE — Supplemental Application (Natco Pharma Limited)

View source ↗

Summary

FDA issued a supplemental approval for Natco Pharma Limited's generic letrozole under an ANDA. Letrozole is used to treat hormone receptor-positive breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)

Snippet

SUPPL AP for LETROZOLE (LETROZOLE)